Actuation Indicator Trial in Patients With COPD
NCT00928746
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE:
Ipratropium bromide
Sponsor
Boehringer Ingelheim